Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.

[1]  A. Trottier,et al.  Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants , 2023, Familial Cancer.

[2]  F. Solé,et al.  European standard clinical practice - Key issues for the medical care of individuals with familial leukemia. , 2023, European journal of medical genetics.

[3]  Paul Liu,et al.  Genomic Landscape of Patients with Germline RUNX1 Variants and Familial Platelet Disorder with Myeloid Malignancy , 2023, bioRxiv.

[4]  Y. Kamatani,et al.  Germline DDX41 mutations define a unique subtype of myeloid neoplasms. , 2022, Blood.

[5]  Anna L. Brown,et al.  Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia. , 2022, Blood.

[6]  Anna L. Brown,et al.  Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies , 2022, Blood advances.

[7]  S. Spellman,et al.  Germline predisposition variants occur in myelodysplastic syndrome patients of all ages. , 2022, Blood.

[8]  B. Ebert,et al.  Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel. , 2022, Blood.

[9]  N. Freedman,et al.  Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes. , 2022, Blood.

[10]  Lundgren S,et al.  Somatic compensation of inherited bone marrow failure. , 2022, Seminars in hematology.

[11]  M. Loh,et al.  International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data. , 2022, Blood.

[12]  G. Castellani,et al.  Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. , 2022, NEJM evidence.

[13]  C. Bellanné-Chantelot,et al.  S162: SOMATIC GENETIC LANDSCAPE IN GATA2 DEFICIENCY PATIENTS , 2022, HemaSphere.

[14]  Anna L. Brown,et al.  Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations , 2022, Blood advances.

[15]  J. Fitzgibbon,et al.  Acquired somatic variants in inherited myeloid malignancies , 2022, Leukemia.

[16]  B. Schumacher,et al.  Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicity , 2022, Nature communications.

[17]  Elizabeth M. Hollinger,et al.  NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[18]  S. Savage,et al.  Disease Progression and Clinical Outcomes in Telomere Biology Disorders. , 2021, Blood.

[19]  T. Kovacsovics,et al.  AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome , 2021, Leukemia.

[20]  C. Dufour,et al.  Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update , 2021, Expert review of hematology.

[21]  B. Han,et al.  Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data , 2021, Therapeutic advances in hematology.

[22]  B. Fadeel,et al.  Kostmann disease and other forms of severe congenital neutropenia , 2021, Acta paediatrica.

[23]  Shondra M. Pruett-Miller,et al.  Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells , 2021, Leukemia.

[24]  Nicholas D. Camarda,et al.  Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome , 2021, Nature Communications.

[25]  D. Neuberg,et al.  The clinical and functional effects of TERT variants in myelodysplastic syndrome , 2021, bioRxiv.

[26]  T. Walsh,et al.  Germline variants drive myelodysplastic syndrome in young adults , 2021, Leukemia.

[27]  S. Ogawa,et al.  Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency. , 2021, Blood.

[28]  J. Klco,et al.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms , 2020, Nature Reviews Cancer.

[29]  L. Godley,et al.  Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities , 2020, British journal of haematology.

[30]  Nicola K. Wilson,et al.  Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans , 2020, Molecular cell.

[31]  M. Wlodarski,et al.  Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes , 2020, Best Practice & Research Clinical Haematology.

[32]  M. Boerries,et al.  Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency , 2020, Leukemia.

[33]  Anna L. Brown,et al.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA). , 2020, Blood.

[34]  Anna L. Brown,et al.  RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML. , 2020, Blood advances.

[35]  D. Steinemann,et al.  The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants , 2020, Nature Communications.

[36]  G. Boucher,et al.  High frequency of germline RUNX1 mutations in RUNX1 mutated AML patients. , 2020, Blood.

[37]  Dongyou Liu.  GATA2 Deficiency , 2020, Handbook of Tumor Syndromes.

[38]  Hong Liu,et al.  Companion gene mutations and their clinical significance in AML with double mutant CEBPA , 2019, Cancer Gene Therapy.

[39]  M. Ozelo,et al.  Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies , 2019, British journal of haematology.

[40]  S. Montoto,et al.  Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors , 2019, Bone Marrow Transplantation.

[41]  J. Di Paola,et al.  ETV6-Related Thrombocytopenia and Leukemia Predisposition. , 2019, Blood.

[42]  I. Ahmed,et al.  Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations , 2019, Biology of Blood and Marrow Transplantation.

[43]  K. Calvo,et al.  Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia , 2019, International journal of laboratory hematology.

[44]  Koichi Takahashi,et al.  Hematologic malignancies and Li–Fraumeni syndrome , 2019, Cold Spring Harbor molecular case studies.

[45]  D. Link.  Mechanisms of leukemic transformation in congenital neutropenia , 2019, Current opinion in hematology.

[46]  C. Pui,et al.  Somatic and germline genomics in paediatric acute lymphoblastic leukaemia , 2018, Nature Reviews Clinical Oncology.

[47]  M. Wlodarski,et al.  SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation , 2018, Blood.

[48]  B. Ko,et al.  GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia , 2018, Blood Cancer Journal.

[49]  T. Vulliamy,et al.  Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants , 2018, Proceedings of the National Academy of Sciences.

[50]  A. Tefferi,et al.  Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms , 2018, British journal of haematology.

[51]  T. Vulliamy,et al.  Expanding the phenotypic and genetic spectrum of radioulnar synostosis associated hematological disease , 2018, Haematologica.

[52]  E. Lemyre,et al.  Refining the phenotype associated with biallelic DNAJC21 mutations , 2018, Clinical genetics.

[53]  Steven J. M. Jones,et al.  Pathogenic Germline Variants in 10,389 Adult Cancers. , 2018, Cell.

[54]  J. Soulier,et al.  A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. , 2018, Blood.

[55]  G. Wertheim,et al.  Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype. , 2018, Blood advances.

[56]  M. Boerries,et al.  Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7 , 2017, Haematologica.

[57]  D. Steinemann,et al.  MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies , 2017, Haematologica.

[58]  P. Rosenberg,et al.  Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up , 2017, Haematologica.

[59]  L. Strong,et al.  Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome , 2017, Clinical Cancer Research.

[60]  L. Godley,et al.  Germline ETV6 mutations and predisposition to hematological malignancies , 2017, International Journal of Hematology.

[61]  Anna L. Brown,et al.  Myeloid neoplasms with germline DDX41 mutation , 2017, International Journal of Hematology.

[62]  T. Fioretos,et al.  Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. , 2017, Blood.

[63]  R. Sood,et al.  Role of RUNX1 in hematological malignancies. , 2017, Blood.

[64]  Matthew Collin,et al.  GATA2 deficiency and related myeloid neoplasms , 2017, Seminars in hematology.

[65]  J. Fitzgibbon,et al.  Familial CEBPA-mutated acute myeloid leukemia. , 2017, Seminars in hematology.

[66]  C. Tailor,et al.  Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome. , 2017, Blood.

[67]  H. Harada,et al.  Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation , 2017, Leukemia.

[68]  R. Sinke,et al.  Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation , 2017, Leukemia.

[69]  W. Ouwehand,et al.  Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors , 2017, Haematologica.

[70]  J. Klco,et al.  The genomic landscape of pediatric myelodysplastic syndromes , 2016, Nature Communications.

[71]  N. Ellis,et al.  Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition , 2016, Molecular Syndromology.

[72]  J. Geigl,et al.  Acute myeloid leukemia with TP53 germ line mutations. , 2016, Blood.

[73]  T. Walsh,et al.  Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[74]  J. Schiffman,et al.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. , 2016, The Lancet. Oncology.

[75]  D. Kelsell,et al.  DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation. , 2016, American journal of human genetics.

[76]  M. Yeager,et al.  Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family , 2016, Haematologica.

[77]  T. Kalina,et al.  Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome , 2016, Haematologica.

[78]  M. Chiarini,et al.  Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia. , 2016, Blood.

[79]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[80]  H. Okano,et al.  SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 , 2016, Nature Genetics.

[81]  O. Abdel-Wahab,et al.  Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia , 2016, Leukemia.

[82]  M. Wlodarski,et al.  Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. , 2016, Blood.

[83]  J. Dalle,et al.  Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes , 2016, International Journal of Hematology.

[84]  T. Walsh,et al.  Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy‐related leukemia , 2016, Cancer.

[85]  J. Gribben,et al.  Disease evolution and outcomes in familial AML with germline CEBPA mutations. , 2015, Blood.

[86]  I. Baumann,et al.  Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only , 2015, Annals of Hematology.

[87]  Christopher A. Miller,et al.  The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.

[88]  J. Orange,et al.  GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. , 2014, Blood.

[89]  Paola Giordano,et al.  ANKRD26-related thrombocytopenia and myeloid malignancies. , 2013, Blood.

[90]  J. Fitzgibbon,et al.  GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations , 2013, British journal of haematology.

[91]  T. Leblanc,et al.  Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome , 2012, Haematologica.

[92]  E. Hoster,et al.  GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. , 2012, Blood.

[93]  J. Gutman,et al.  A novel CCAAT/enhancer binding protein α germline variant in a case of acute myeloid leukemia , 2012, Leukemia & lymphoma.

[94]  Anna L. Brown,et al.  Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia , 2011, Nature Genetics.

[95]  P. Noris,et al.  Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. , 2011, Blood.

[96]  M. Wlodarski,et al.  Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA. , 2011, Blood.

[97]  He Huang,et al.  First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. , 2011, Blood.

[98]  F. Sigaux,et al.  Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. , 2011, Blood.

[99]  Erdogan Taskesen,et al.  Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. , 2011, Blood.

[100]  Bertil Johansson,et al.  Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia , 2010, Proceedings of the National Academy of Sciences.

[101]  B. Leber,et al.  Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. , 2008, Blood.

[102]  T. Pabst,et al.  Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  D. Gilliland.  The Genetics of Acute Myeloid Leukemias , 2007 .

[104]  A. Børresen-Dale,et al.  TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes , 2007, Oncogene.

[105]  T. Lister,et al.  Mutation of CEBPA in familial acute myeloid leukemia. , 2004, The New England journal of medicine.

[106]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[107]  L. Godley,et al.  How I diagnose and manage individuals at risk for inherited myeloid malignancies. , 2016, Blood.

[108]  J. Wagner,et al.  Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics. , 2010, American journal of clinical pathology.

[109]  J. Lipton,et al.  Marrow failure. , 2004, Hematology. American Society of Hematology. Education Program.